Washington
-
Establishing a Pathway to Access Psilocybin for Use with Patients with Advanced Illness: UPDATE
As counsel to Dr. Sunil Aggarwal of the Advanced Integrative Medical Science (“AIMS”) Institute we have been seeking authorization for…
-
Landmark Petition to Reschedule Psilocybin filed with DEA
Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in alignment with ongoing international research on…
-
Ninth Circuit ducks merits in nation’s first legal challenge to allow access to psilocybin in end-of-life care under “Right-To-Try” laws
Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in alignment with ongoing international research…
-
Why I Do What I Do: Representing patients with advanced illness
I represent Erinn Baldeschwiler in AIMS et al v DEA. Erinn is faced with advanced cancer, and the prospect of…
-
Opening Access to Psilocybin Therapy for Seriously Ill Patients: The Petitioners’ Opening Brief in AIMS et al v DEA
Emerge Law Group is proud to represent a Seattle palliative care physician and co-director of an integrative oncology clinic, and…
-
Opening access to psilocybin therapy for those with life-threatening illnesses
Multiple recently conducted clinical trials show that therapy with psilocybin for relief of anxiety and depression in patients with advanced…
-
Our Current Overview of State and Local Responses to EVALI to Date
Late 2019 saw a national outbreak in hospitalized cases of e-cigarette or vaping product use associated lung injury (EVALI). The…
-
Overhaul of WA Medical Marijuana Program
Last Friday, Washington Governor Jay Inslee signed into law Senate Bill 5052, also known as the Cannabis Patient Protection Act. …
-
Oregon Ballot Measure 91, better than Washington I-502?
As we get closer to the November election and the potential (likely?) passage of Ballot Measure 91 in Oregon,…